Cartesian Therapeutics Inc. (NASDAQ: RNAC) Stock Information | RedChip

Cartesian Therapeutics Inc. (NASDAQ: RNAC)


$19.1050
+0.0850 ( +0.87% ) 12.7K

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Market Data


Open


$19.1050

Previous close


$19.0200

Volume


12.7K

Market cap


$483.14M

Day range


$18.0700 - $19.6550

52 week range


$11.6650 - $41.8700

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 5 Jan 04, 2024
4 Insider transactions 5 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 5 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 1 Jan 04, 2024
4 Insider transactions 5 Jan 04, 2024

Latest News